Fiche centre
Shin Kong Wu Ho-Su Memorial Hospital
Taipei — Taiwan
Essais liés6clinical trials
VilleTaipeilocalisation
PaysTaiwanlocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06531824
Essais cliniques associés
6| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Empagliflozin 25 MG | Insuffisance cardiaque | Phase 4 | NCT06249932 | EMPA-RRED — Empagliflozin in Heart Failure With Reduced Ejection Fraction and End Stage Renal Disease | RECRUITING |
| BI 690517 | Maladie rénale chronique | Phase 3 | NCT06531824 | EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) | ACTIVE_NOT_RECRUITING |
| Depressive Tendency and Counseling Outcomes in Thymoma-Associated MG | Myasthénie | Non applicable | NCT07649187 | Depressive Tendency and Counseling Outcomes in Thymoma-Associated MG | COMPLETED |
| Cladribine Low Dose | Myasthénie | Phase 3 | NCT06463587 | Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad) | RECRUITING |
| Bu Zhong Yi Qi Tang | Myasthénie | NA | NCT06881173 | The Effectiveness of Bu Zhong Yi Qi Tang in Patients with Myasthenia Gravis | RECRUITING |
| Psychological Health and Adverse Childhood Experiences in Myasthenia Gravis: Online Mental Health BMI Learning Program | Myasthénie | NA | NCT07291713 | Psychological Health and Adverse Childhood Experiences in Myasthenia Gravis: Online Mental Health BMI Learning Program | COMPLETED |